Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia. [electronic resource]
Producer: 20131119Description: 573-80 p. digitalISSN:- 1865-3774
- Age Factors
- Alemtuzumab
- Anemia, Aplastic -- complications
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antigens, CD
- Antigens, Neoplasm
- CD52 Antigen
- Glycoproteins -- antagonists & inhibitors
- Graft vs Host Disease -- etiology
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunosuppressive Agents -- therapeutic use
- Infections -- etiology
- Transplantation Conditioning
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.